Antiproliferative activity of methylated analogues of E- and Z-resveratrol

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 62, Issue 3-4, 2007, Pages 189-195

  Cardile, Venera ^a   Chillemi, Rosa ^a   Lombardo, Laura ^a   Sciuto, Sebastiano ^a   Spatafora, Carmela ^a   Tringali, Corrado ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antiproliferative activity; Resveratrol analogues

Indexed keywords

DRUG DERIVATIVE; NAVELBINE; RESVERATROL; STILBENE DERIVATIVE; VINBLASTINE;

ANIMAL; ARTICLE; CELL DIVISION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; ISOLATION AND PURIFICATION; ISOMERISM; MASS SPECTROMETRY; METHYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CHROMATOGRAPHY, THIN LAYER; ISOMERISM; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METHYLATION; NEOPLASMS, EXPERIMENTAL; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; VINBLASTINE;

EID: 34547411544     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2007-3-406     Document Type: Article

References (23)

1. Aggarwal B. B. and Shishodia S. (eds.) (2006), Oxidative Stress and Disease, Vol 20, Resveratrol in Health and Disease. CRC Press LLC, Boca Raton, FL, pp. 1-712.
2. Belguendouz L., Fremont L., and Linard A. (1997), Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53, 1347-1355.
3. Bradamante S., Barenghi L., and Villa A. (2004), Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 22, 169-188.
4. Cardile V., Lombardo L., Spatafora C., and Tringali C. (2005), Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorg. Chem. 33, 22-33.
5. Cushman M., Nagarathnam D., Gopal D., He H. M., Lin C. M., and Hamel E. (1992), Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4, 5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. J. Med. Chem. 35, 2293-2306.
6. Garvin S., Oellinger K., and Dabrosin C. (2006), Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 231, 113-122.
7. Gehm B. D., McAndrews J. M., Chien P.-Y., and Jameson J. L. (1997), Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94, 14138-14143.
8. Gonzales M. J. T. G., Pinto M. M. M., Kijjoa A., Anantachoke C., and Herz W. (1993), Stilbenes and other constituents of Knema austrosiamensis. Phytochemistry 32, 433-438.
9. Jang M., Cai L., Udeani G. O., Slowing K. V., Thomas C. F., Beecher C. W. W., Fong H. H. S., Farnsworth N. R., Kinghorn A. D., Mehta R. G., Moon R. C., and Pezzuto J. M. (1997), Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
10. Joe A. K., Liu H., Suzui M., Vural M. E., Xiao D., and Weinstein I. B. (2002), Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res 8, 893-903.
11. 13C NMR spectra of resveratrol derivatives. Magn. Res. Chem. 39, 768-770.
12. Kuo P.-L., Chiang L.-C., and Lin C.-C. (2002), Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72, 23-34.
13. Maccarrone M., Lorenzon T., Guerrieri P., and Finazzi Agrò A. (1999), Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265, 27-34.
14. Mannila E., Talvitie A., and Kolehmainen E. (1993), Anti-leukaemic compounds derived from stilbenes in Picea abies bark. Phytochemistry 33, 813-816.
15. Mosmann T. (1983), Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-63.
16. Pace-Asciak C. R., Rounova O., Hahn S. E., Diamandis E. P., and Goldberg D. M. (1996), Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta 246, 163-182.
17. Pettit G. R., Singh S. B., Boyd M. R., Hamel E., Pettit R. K., Schmidt J. M., and Hogan F. (1995), Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a). J. Med. Chem. 38, 1666-1672.
18. Pettit G. R., Grealish M. P., Jung M. K., Hamel E., Pettit R. K., Chapuis J.-C., and Schmidt J. M. (2002), Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. J. Med. Chem. 45, 2534-2542.
19. Renaud S. and de Lorgeril M. (1992), Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
20. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., Buscemi F., Grimaudo S., and Tolomeo M. (2003), Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 46, 3546-3554.
21. Schneider Y., Vincent F., Duranton B., Badolo L., Gosse F., Bergmann C., Seiler N., and Raul F. (2000), Antiproliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85-91.
22. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Gosse F., Launay J.-F., Brouillard R., and Raul F. (2003), Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int. J. Cancer 107, 189-196.
23. Sun N. J., Woo S. H., Cassady J. M., and Snapka R. M. (1998), DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61, 362-366.